Last reviewed · How we verify
oxybutynin IR
oxybutynin IR is a Small molecule drug developed by Allergan. It is currently FDA-approved. Also known as: Ditropan.
Oxybutynin IR is a small molecule that acts as a muscarinic acetylcholine receptor M3 antagonist. It is used to treat conditions such as overactive bladder and neurogenic detrusor overactivity, particularly in individuals with spinal cord injuries.
At a glance
| Generic name | oxybutynin IR |
|---|---|
| Also known as | Ditropan |
| Sponsor | Allergan |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
- A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment (PHASE2)
- Mirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury (PHASE2)
- Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial (PHASE4)
- Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- oxybutynin IR CI brief — competitive landscape report
- oxybutynin IR updates RSS · CI watch RSS
- Allergan portfolio CI
Frequently asked questions about oxybutynin IR
What is oxybutynin IR?
Who makes oxybutynin IR?
Is oxybutynin IR also known as anything else?
What development phase is oxybutynin IR in?
Related
- Manufacturer: Allergan — full pipeline
- Also known as: Ditropan
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing